GW Pharmaceuticals Plc (GWPH) financial statements (2020 and earlier)

Company profile

Business Address SOVEREIGN HOUSE
HISTON, CAMBRIDGE CB24 9BZ, 00000
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
9/30/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments537355
Cash and cash equivalents537355
Receivables492
Inventory, net of allowances, customer advances and progress billings8619
Inventory8619
Other undisclosed current assets2815
Total current assets:700391
Noncurrent Assets
Finance lease, right-of-use asset6
Operating lease, right-of-use asset25
Property, plant and equipment12882
Intangible assets, net (including goodwill)77
Goodwill77
Other noncurrent assets53
Deferred tax assets, net7
Other undisclosed noncurrent assets13 
Total noncurrent assets:183100
TOTAL ASSETS:882491
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities11058
Accounts payable1010
Accrued liabilities9947
Taxes payable01
Other liabilities81
Total current liabilities:11859
Noncurrent Liabilities
Long-term debt and lease obligation272
Finance lease, liability6
Capital lease obligations2
Operating lease, liability22
Liabilities, other than long-term debt1111
Other liabilities1111
Other undisclosed noncurrent liabilities 4
Total noncurrent liabilities:3917
Total liabilities:15675
Stockholders' equity
Stockholders' equity attributable to parent726415
Common stock11
Additional paid in capital1,6321,247
Accumulated other comprehensive loss(69)(75)
Accumulated deficit(838)(757)
Total stockholders' equity:726415
TOTAL LIABILITIES AND EQUITY:882491

Income statement (P&L) ($ in millions)

12/31/2019
9/30/2018
Revenues31113
Cost of revenue(131)(6)
Cost of goods and services sold(27)(6)
Gross profit:1807
Operating expenses(299)(296)
Operating loss:(118)(289)
Nonoperating income (expense)110(1)
Investment income, nonoperating84
Foreign currency transaction loss, before tax(2)(5)
Other nonoperating income104 
Interest and debt expense(1)(1)
Loss from continuing operations before income taxes:(9)(291)
Income tax expense (benefit)0(4)
Net loss available to common stockholders, diluted:(9)(295)

Comprehensive Income ($ in millions)

12/31/2019
9/30/2018
Net loss:(9)(295)
Comprehensive loss:(9)(295)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent10(1)
Comprehensive income (loss), net of tax, attributable to parent:1(296)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: